Drug and Therapeutics Bulletin 1997;35:49-52; doi:10.1136/dtb.1997.35749
Copyright © 1997 by the BMJ Publishing Group Ltd.
Drug-induced agranulocytosis
Drug-induced agranulocytosis is a rare, potentially fatal idiosyncratic reaction that can occur unpredictably with a wide variety of drugs when taken in a conventional dose. In this article, we discuss its diagnosis and management and we consider the drugs most commonly involved and ways of minimising risk. We do not consider the dose-related granulocytopenia that commonly complicates treatment with cytotoxic and other myelosuppressant drugs, nor the rarer reaction, aplastic anaemia.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
-
Smellie, W S A, Forth, J, Sundar, S, Kalu, E, McNulty, C A M, Sherriff, E, Watson, I D, Croucher, C, Reynolds, T M, Carey, P J
(2006). Best practice in primary care pathology: review 4. J. Clin. Pathol.
59: 893-902
[Abstract] [Full Text] -
Hanna, F W F, Lazarus, J H, Scanlon, M F
(1999). Fortnightly review: Controversial aspects of thyroid disease. BMJ
319: 894-899
[Full Text] -
(1997). ELABORATION: Drug-induced agranulocytosis - monitoring antithyroid treatment. DTB
35: 88-88
[Full Text]
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for email alerts
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Coming soon!
The DTB archive back to 1962, volume 1, issue 1 will soon be available.
